Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2020 - 2027

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third-party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6.数据验证和发布
1.7. Model Details
1.8. Commodity Flow Analysis
1.9. Approach: Commodity Flow Approach
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.12. Objective
1.13. Objective 1
1.14. Objective 2
1.15. Objective 3
1.16. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Castrate-Resistant Prostate Cancer Market Variables, Trends & Scope
3.1. Castrate-Resistant Prostate Cancer Market Lineage outlook
3.1.1. Parent market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. User Perspective Analysis
3.4. Regulatory Framework
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.1.1. Rising prevalence of castrate-resistant prostate cancer
3.5.1.2. Increasing technological advancements
3.5.1.3. Rising adoption of treatment
3.5.2. Market restraint analysis
3.5.2.1. Lack of standard therapy
3.6. Castrate-Resistant Prostate Cancer Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
Chapter 4. Castrate-Resistant Prostate Cancer Market: Therapy Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Therapy Market Share Analysis, 2019 & 2027
4.3. Therapy Dashboard
4.4. Castrate-Resistant Prostate Cancer Market, By Therapy, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
4.5.1. Chemotherapy
4.5.1.1. Chemotherapy market, 2016 - 2027 (USD Million)
4.5.2. Hormonal Therapy
4.5.2.1. Hormonal therapy market, 2016 - 2027 (USD Million)
4.5.3. Immunotherapy
4.5.3.1. Immunotherapy market, 2016 - 2027 (USD Million)
4.5.4. Radiotherapy
4.5.4.1. Radiotherapy market, 2016 - 2027 (USD Million)
Chapter 5. Castrate-resistant Prostate Cancer Market: Segment Analysis, By Region, 2016 - 2027 (USD Million)
5.1 Castrate-resistant Prostate Cancer Market, Market Share by Region, 2019 & 2027
5.1.1 North America
5.1.1.1 North America market estimates and forecast, 2015 - 2027 (USD Million)
5.1.1.2 U.S.
5.1.1.2.1 U.S. market estimates and forecast, 2015 - 2027 (USD Million)
5.1.1.3 Canada
5.1.1.3.1 Canada market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2 Europe
5.1.2.1 Europe market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.2 U.K.
5.1.2.2.1 U.K. market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.3 Germany
5.1.2.3.1 Germany market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.4 France
5.1.2.4.1 France market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.5 Spain
5.1.2.5.1 Spain market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.6 Italy
5.1.2.6.1 Italy market estimates and forecast, 2015 - 2027 (USD Million)
5.1.2.7 Russia
5.1.2.7.1 Russia market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3 Asia Pacific
5.1.3.1 Asia Pacific market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.2 Japan
5.1.3.2.1 Japan market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.3 China
5.1.3.3.1 China market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.4 India
5.1.3.4.1 India market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.5 South Korea
5.1.3.5.1 South Korea market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.6 Singapore
5.1.3.6.1 Singapore market estimates and forecast, 2015 - 2027 (USD Million)
5.1.3.7 Australia
5.1.3.7.1 Australia market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4 Latin America
5.1.4.1 Latin America market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.2 Brazil
5.1.4.2.1 Brazil market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.3 Mexico
5.1.4.3.1 Mexico market estimates and forecast, 2015 - 2027 (USD Million)
5.1.4.4 Argentina
5.1.4.4.1 Argentina market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6 Middle East and Africa
5.1.6.1 Middle East & Africa market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.2 South Africa
5.1.6.2.1 South Africa market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.3 UAE
5.1.6.3.1 UAE market estimates and forecast, 2015 - 2027 (USD Million)
5.1.6.4 Saudi Arabia
5.1.6.4.1 Saudi Arabia market estimates and forecast, 2015 - 2027 (USD Million)
Chapter 6. Company Profiles
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Public Companies
6.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.3.2. Competitive dashboard analysis
6.3.3. Market differentiators
6.4. Private Companies
6.5. Company Profiles
6.5.1. Sanofi
6.5.1.1. Company Overview
6.5.1.2. Financial Performance
6.5.1.3. Product Benchmarking
6.5.1.4. Strategic Initiatives
6.5.2. Johnson & Johnson Services Inc.
6.5.2.1. Company Overview
6.5.2.2. Financial Performance
6.5.2.3. Product Benchmarking
6.5.2.4. Strategic Initiatives
6.5.3. Pfizer Inc.
6.5.3.1. Company Overview
6.5.3.2. Financial Performance
6.5.3.3. Product Benchmarking
6.5.3.4. Strategic Initiatives
6.5.4. Astellas Pharma, Inc.
6.5.4.1. Company Overview
6.5.4.2. Financial Performance
6.5.4.3. Product Benchmarking
6.5.4.4. Strategic Initiatives
6.5.5. Bayer AG
6.5.5.1. Company Overview
6.5.5.2. Financial Performance
6.5.5.3. Product Benchmarking
6.5.5.4. Strategic Initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global Castrate-resistant Prostate Cancer Market, By Region, 2016 - 2027 (USD Million)
TABLE 5 Global Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 6 North America Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 7 North America Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 8 U.S. Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 9 Canada Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 10 Europe Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 11 Europe Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 12 U.K. Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 13 Germany Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 14 France Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 15 Spain Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 16 Italy Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 17 Russia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 18 Asia Pacific Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 19 Asia Pacific Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
表中国20 Castrate-resistant前列腺癌Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 21 Japan Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 22 India Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 23 South Korea Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 24 Singapore Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 25 Australia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 26 Latin America Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 27 Latin America Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 28 Brazil Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 29 Mexico Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 30 Argentina Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 31 MEA Castrate-resistant Prostate Cancer Market, By Country, 2016 - 2027 (USD Million)
TABLE 32 MEA Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 33 South Africa Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 34 UAE Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)
TABLE 35 Saudi Arabia Castrate-resistant Prostate Cancer Market, By Therapy, 2016 - 2027 (USD Million)

List of Figures

FIG. 1 Castrate-resistant Prostate Cancer Market Segmentation
FIG. 2 Market Research Process
FIG. 3 Information Procurement
FIG. 4 Primary Research Pattern
FIG. 5 Market Research Approaches
FIG. 6 Value-Chain-Based Sizing & Forecasting
FIG. 7 QFD Modeling for Market Share Assessment
FIG. 8 Market Formulation & Validation
FIG. 9 Castrate-resistant Prostate Cancer Market Snapshot
FIG. 10 Castrate-resistant Prostate Cancer Market Driver Impact
FIG. 11 Castrate-resistant Prostate Cancer Market Restraint Impact
FIG. 12 Penetration and Growth Prospect Mapping
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 SWOT Analysis, By Factor (Political & Legal Economic and Technological)
FIG. 15 Therapy Market Share Analysis, 2019 & 2027
FIG. 16 Therapy Dashboard
FIG. 17 Chemotherapy Market, 2016 - 2027 (USD Million)
FIG. 18 Hormonal Therapy Market, 2016 - 2027 (USD Million)
FIG. 19 Immunotherapy Derivatives Market, 2016 - 2027 (USD Million)
FIG. 20 Radiotherapy Market, 2016 - 2027 (USD Million)
FIG. 21 Castrate-resistant Prostate Cancer Market, Market Share by Region, 2019 & 2027
FIG. 22 North America
FIG. 23 North America Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 24 U.S.
FIG. 25 U.S. Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 26 Canada
FIG. 27 Canada Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 28 Europe
FIG. 29 Europe Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 30 U.K.
FIG. 31 U.K. Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 32 Germany
FIG. 33 Germany Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 34 France
FIG. 35 France Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 36 Spain
FIG. 37 Spain Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 38 Italy
FIG. 39 Italy Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 40 Russia
FIG. 41 Russia Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 42 Asia Pacific
FIG. 43 Asia Pacific Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 44 Japan
FIG. 45 Japan Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 46 China
FIG. 47 China Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 48 India
FIG. 49 India Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 50 South Korea
FIG. 51 South Korea Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 52 Singapore
FIG. 53 Singapore Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 54 Australia
FIG. 55 Australia Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 56 Latin America
FIG. 57 Latin America Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 58 Brazil
FIG. 59 Brazil Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 60 Mexico
FIG. 61 Mexico Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 62 Argentina
图63年阿根廷市场Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 64 Middle East & Africa
FIG. 65 Middle East & Africa Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 66 South Africa
FIG. 67 South Africa Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 68 UAE
FIG. 69 UAE Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 70 Saudi Arabia
FIG. 71 Saudi Arabia Market Estimates and Forecast, 2016 - 2027 (USD Million)
FIG. 72 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
FIG. 73 Competitive Dashboard Analysis
FIG. 74 Market Differentiators